How we’re leveraging each other’s unique strengths to help advance cancer research

By Teresa Cronin As we celebrate National Nurses Month, Eisai would like to pay special tribute to the nurses who inspire all of us, and in particular to Florence Nightingale as she was the...

As we recognize National Women’s Health Week, I consider how far collectively academia, the clinical community and industry have come in advancing treatments for women’s cancers. Work to...

By Renee Campbell, MD, MBA, MPH, Global Value and Access Epilepsy and Sleep lead, Genevieve De Sousa Meier, Executive Director, Head of Global Value and Access, and Amir Abbas Tahami Monfared,...

By Feride Frech, PhD, MPH, Senior Director, US HEOR & RWE, Eisai Inc, and Timothy Juday, Director, US HEOR & RWE, Eisai Inc. Insomnia, the most common sleep-wake disorder, is prevalent in the...

Harald Hampel, MD, PhD Vice President, Chief Medical Officer, Neurology Business Group, Eisai Inc. Alzheimer’s disease (AD) is a devastating neurodegenerative disease. It is estimated to affect...

By Jeff Somers, For years, the treatment of Alzheimer’s disease focused on symptoms. New research targets the pathophysiological changes underneath — with potentially promising results....

Though many people with insomnia go into doctor’s visits expecting a drug to relieve their sleeplessness, stakeholders are moving increasingly toward holistic approaches. Clinicians, medical...

It is no surprise that sleep problems are on the rise due to life changes caused by the coronavirus disease 2019 (COVID-19) pandemic. Based on my experience, the current environment, with myriad...

The European Society for Medical Oncology (ESMO) Virtual Congress 2020 took place from September 19-21. The theme of this year’s conference was “Bringing Innovation to Cancer Care”. Our...